Insights and Discoveries

New Generation Products (NGP) represent a global shift toward harm reduction and innovation in nicotine consumption. Unlike traditional cigarettes, NGPs deliver nicotine through non-combustion mechanisms — significantly lowering exposure to toxic compounds while offering more personalized user experiences. This article explores the three major NGP categories — E-cigarettes (ENDS), Heated Tobacco (HNB), and Oral Nicotine — comparing their principles, health impacts, market dynamics, and regulatory trends.

On the world map of the tobacco industry, the InterTabac trade fair in Dortmund is undoubtedly one of the most influential stages of the year. Every September, it serves not only as a showcase for products but also as a barometer for industry trends. In 2025, this stage welcomed a particularly notable presence — Hong Kong Nanyang Brothers Tobacco, a company with over a century of history.

This insight examines the evolving user landscape of oral nicotine products through two representative markets — Sweden, where oral nicotine has deep cultural roots in snus, and the United States, where regulation and innovation drive adoption. In Sweden, nicotine pouch usage is rapidly expanding among younger and female consumers, signaling a lifestyle-driven trend. In contrast, U.S. consumers remain predominantly male and middle-aged, often combining oral nicotine with other nicotine products. Together, these cases reveal how policy frameworks, cultural acceptance, and health perceptions shape the global oral nicotine movement.

This insight outlines the current landscape of the global oral nicotine market — including user demographics, market size, structural evolution, and product segmentation. With the rise of tobacco-free nicotine pouches, the industry is witnessing rapid transformation driven by health awareness, flexible regulation, and innovation in product formulation.

This insight reviews the global regulatory landscape of nicotine pouches — a rapidly growing tobacco-free nicotine format. From Europe’s fragmented oversight to the FDA’s structured PMTA pathway and Asia-Pacific’s restrictive stance, the report outlines how regulation defines market maturity, innovation direction, and compliance strategy across regions.

This insight explores the key forces shaping the global oral nicotine market — from policy evolution and consumer behavior to corporate strategies. It also highlights the major challenges ahead, including regulatory tightening, illegal trade, and shifting consumption habits.